ICD-10 Specific code L94.5: Poikiloderma vasculare atrophicans
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Poikiloderma vasculare atrophicans |
French
|
Poïkilodermie généralisée type Petges-Cléjat [atrophiante vasculaire] |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | XII | Diseases of the skin and subcutaneous tissue | |
| 2 | L80-L99 | Other disorders of the skin and subcutaneous tissue | |
| 3 | L94 | Other localized connective tissue disorders | |
| 4 | L94.5 | Poikiloderma vasculare atrophicans |
Indicated medicines
| Active Ingredient |
|---|
|
Cetrimide is a quaternary ammonium cationic disinfectant with bactericidal activity against gram-positive and some gram-negative organisms. Cetrimide is relatively ineffective against viruses. |
|
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
|
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |